| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1081/CBI-120002600 |
| P698 | PubMed publication ID | 11962679 |
| P2093 | author name string | Patricia A Wood | |
| William J M Hrushesky | |||
| Minoru Kobayashi | |||
| P2860 | cites work | Chemotherapy of advanced ovarian cancer with 4'-O-tetrahydropyranyl doxorubicin and cisplatin: a randomized phase II trial with an evaluation of circadian timing and dose-intensity | Q33396400 |
| Circadian continuous chemotherapy of renal cell carcinoma with an implantable, programmable infusion pump | Q45027024 | ||
| A phase II study of constant-infusion floxuridine for the treatment of metastatic renal cell carcinoma. | Q45942083 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | circadian rhythm | Q208353 |
| chemotherapy | Q974135 | ||
| P304 | page(s) | 237-251 | |
| P577 | publication date | 2002-01-01 | |
| P1433 | published in | Chronobiology International | Q2025696 |
| P1476 | title | Circadian chemotherapy for gynecological and genitourinary cancers | |
| P478 | volume | 19 |
| Q48448796 | Alterations of the characteristics of the circadian rest-activity rhythm of cancer in-patients. |
| Q38934513 | Chronotherapy in practice: the perspective of the community pharmacist. |
| Q35691235 | Circadian Clock Gene CRY2 Degradation Is Involved in Chemoresistance of Colorectal Cancer. |
| Q38545148 | Circadian Clocks in the Hematologic System |
| Q24602881 | Circadian clock control of the cellular response to DNA damage |
| Q36139993 | Circadian clock genes as modulators of sensitivity to genotoxic stress. |
| Q24304122 | Circadian control of XPA and excision repair of cisplatin-DNA damage by cryptochrome and HERC2 ubiquitin ligase |
| Q33402391 | Circadian oscillation of nucleotide excision repair in mammalian brain |
| Q44696606 | Circadian rhythms in toxic effects of the serotonin antagonist ondansetron in mice |
| Q43264825 | Circadian time-dependent chemopreventive potential of withaferin-A in 7,12-dimethylbenz[a]anthracene-induced oral carcinogenesis. |
| Q39772578 | Circadian time-dependent tumor suppressor function of period genes |
| Q35702412 | Circadian timing in cancer treatment: the biological foundation for an integrative approach |
| Q29031212 | Clinical Aspects of Human Circadian Rhythms |
| Q50023169 | Development of bacteria-based microrobot using biocompatible poly(ethylene glycol). |
| Q37347756 | Disruption of the circadian clock due to the Clock mutation has discrete effects on aging and carcinogenesis. |
| Q73685097 | Dosing-time-dependent variation in biliary excretion of flomoxef in rats |
| Q34606456 | From circadian rhythms to cancer chronotherapeutics |
| Q28543702 | Inhibition effect of a custom peptide on lung tumors |
| Q37324097 | Light-at-night, circadian disruption and breast cancer: assessment of existing evidence |
| Q37081282 | Loss of cryptochrome reduces cancer risk in p53 mutant mice |
| Q59064387 | Medicine’s secret ingredient — it’s in the timing |
| Q37638137 | Metabolism and cancer: the circadian clock connection |
| Q39000873 | Monocyte-based microrobot with chemotactic motility for tumor theragnosis |
| Q44268701 | Pharmacological blockage of serotonin biosynthesis and circadian changes in oxaliplatin toxicity in rats |
| Q46333551 | Seasonal modulation of the 8-and 24-hour rhythms of ondansetron tolerance in mice |
| Q102388858 | Single cell profiling of capillary blood enables out of clinic human immunity studies |
| Q35013139 | The circadian clock gene Per1 suppresses cancer cell proliferation and tumor growth at specific times of day. |
| Q37141089 | The clock proteins, aging, and tumorigenesis |
| Q37076339 | The influence of circadian rhythms on the kinetics of drugs in humans |
| Q36752281 | The role of mammalian circadian proteins in normal physiology and genotoxic stress responses. |
| Q90642449 | Training the Circadian Clock, Clocking the Drugs, and Drugging the Clock to Prevent, Manage, and Treat Chronic Diseases |
| Q33943901 | Tumor-specific targeting of an anticancer drug delivery system by LHRH peptide. |
| Q35213029 | Use of biotin targeted methotrexate-human serum albumin conjugated nanoparticles to enhance methotrexate antitumor efficacy |
| Q28077467 | WOMEN IN CANCER THEMATIC REVIEW: Circadian rhythmicity and the influence of 'clock' genes on prostate cancer |
Search more.